| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.29 | 5e-14 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-11 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.24 | 8e-11 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.24 | 6e-10 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.26 | 8e-10 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-09 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.3 | 5e-08 |